abstract |
The groups R1-R5, X, Z and R7a, R7b and R7c are defined as in claim 1 and the D-xylopyranosyl-substituted phenyl of general formula (I) is inhibited by the sodium-dependent glucose-cotransporter SGLT Show the effect. The invention also relates to a medicament for treating metabolic diseases. [Chemical 1] |